|
1
|
Li X, Li J, Ou YJ, Zhu XX, Yin XY, Zhu YX
and Tang D: Hepatoprotective effect of ulinastatin in a rat model
of major hepatectomy after obstructive jaundice. Dig Dis Sci.
60:1680–1689. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pavlidis ET and Pavlidis TE:
Pathophysiological consequences of obstructive jaundice and
perioperative management. Hepatobiliary Pancreat Dis Int. 17:17–21.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Unal Y, Tuncal S, Kosmaz K, Kucuk B,
Kismet K, Cavusoglu T, Celepli P, Senes M, Yildiz S and Hucumenoglu
S: The effect of calcium dobesilate on liver damage in experimental
obstructive jaundice. J Invest Surg. 32:238–244. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu Q, Li BS, Song YJ, Hu MG, Lu JY, Gao
A, Sun XJ, Guo XM and Liu R: Hydrogen-rich saline protects against
mitochondrial dysfunction and apoptosis in mice with obstructive
jaundice. Mol Med Rep. 13:3588–3596. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fang D, He Y and Luan Z: Simvastatin
augments activation of liver regeneration through attenuating
transforming growth factor-beta1 induced-apoptosis in obstructive
jaundice rats. Exp Ther Med. 14:4839–4845. 2017.PubMed/NCBI
|
|
6
|
Monteiro MEL, Xavier AR and Azeredo VB:
Diet and liver apoptosis in rats: A particular metabolic pathway.
Nutr Hosp. 34:463–468. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang H, Zhang Y, Bai R, Wang M and Du S:
Baicalin attenuates alcoholic liver injury through modulation of
hepatic oxidative stress, Inflammation and Sonic hedgehog pathway
in rats. Cell Physiol Biochem. 39:1129–1140. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen Z, Ding T and Ma CG: Dexmedetomidine
(DEX) protects against hepatic ischemia/reperfusion (I/R) injury by
suppressing inflammation and oxidative stress in NLRC5 deficient
mice. Biochem Biophys Res Commun. 493:1143–1150. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang ZX, Huang CY, Hua YP, Huang WQ, Deng
LH and Liu KX: Dexmedetomidine reduces intestinal and hepatic
injury after hepatectomy with inflow occlusion under general
anaesthesia: A randomized controlled trial. Br J Anaesth.
112:1055–1064. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang X, Wang J, Qian W, Zhao J, Sun L,
Qian Y and Xiao H: Dexmedetomidine inhibits tumor necrosis
factor-alpha and interleukin-6 in lipopolysaccharide-stimulated
astrocytes by suppression of c-Jun N-terminal kinases.
Inflammation. 37:942–949. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Meng L, Li L, Lu S, Li K, Su Z, Wang Y,
Fan X, Li X and Zhao G: The protective effect of dexmedetomidine on
LPS-induced acute lung injury through the HMGB1-mediated
TLR4/NF-kappaB and PI3K/Akt/mTOR pathways. Mol Immunol. 94:7–17.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tag CG, Weiskirchen S, Hittatiya K, Tacke
F, Tolba RH and Weiskirchen R: Induction of experimental
obstructive cholestasis in mice. Lab Anim. 49 (Suppl 1):S70–S80.
2015. View Article : Google Scholar
|
|
13
|
Taniguchi T, Kidani Y, Kanakura H,
Takemoto Y and Yamamoto K: Effects of dexmedetomidine on mortality
rate and inflammatory responses to endotoxin-induced shock in rats.
Crit Care Med. 32:1322–1326. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Maillette de Buy Wenniger L and Beuers U:
Bile salts and cholestasis. Dig Liver Dis. 42:409–418. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sokol RJ, Dahl R, Devereaux MW, Yerushalmi
B, Kobak GE and Gumpricht E: Human hepatic mitochondria generate
reactive oxygen species and undergo the permeability transition in
response to hydrophobic bile acids. J Pediatr Gastroenterol Nutr.
41:235–243. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Masud A, Mohapatra A, Lakhani SA,
Ferrandino A, Hakem R and Flavell RA: Endoplasmic reticulum
stress-induced death of mouse embryonic fibroblasts requires the
intrinsic pathway of apoptosis. J Biol Chem. 282:14132–14139. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lv M, Zeng H, He Y, Zhang J and Tan G:
Dexmedetomidine promotes liver regeneration in mice after 70%
partial hepatectomy by suppressing NLRP3 inflammasome not
TLR4/NFkappaB. Int Immunopharmacol. 54:46–51. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jiang L, Hu M, Lu Y, Cao Y, Chang Y and
Dai Z: The protective effects of dexmedetomidine on ischemic brain
injury: A meta-analysis. J Clin Anesth. 40:25–32. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gong Z, Ma L, Zhong YL, Li J, Lv J and Xie
YB: Myocardial protective effects of dexmedetomidine in patients
undergoing cardiac surgery: A meta-analysis and systematic review.
Exp Ther Med. 13:2355–2361. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang L and Yu WF: Obstructive jaundice and
perioperative management. Acta Anaesthesiol Taiwan. 52:22–29. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tufek A, Tokgoz O, Aliosmanoglu I,
Alabalik U, Evliyaoglu O, Ciftci T, Guzel A and Yildirim ZB: The
protective effects of dexmedetomidine on the liver and remote
organs against hepatic ischemia reperfusion injury in rats. Int J
Surg. 11:96–100. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kucuk A, Yaylak F, Cavunt-Bayraktar A,
Tosun M, Arslan M, Comu FM and Kavutcu M: The protective effects of
dexmedetomidine on hepatic ischemia reperfusion injury. Bratisl Lek
Listy. 115:680–684. 2014.PubMed/NCBI
|
|
23
|
Venn RM, Bryant A, Hall GM and Grounds RM:
Effects of dexmedetomidine on adrenocortical function, and the
cardiovascular, endocrine and inflammatory responses in
post-operative patients needing sedation in the intensive care
unit. Br J Anaesth. 86:650–656. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang H, Hu B, Zou Y, Bo L, Wang J, Li J
and Luo Y: Dexmedetomidine premedication attenuates concanavalin
A-induced hepatitis in mice. J Toxicol Sci. 39:755–764. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhu YM, Wang CC, Chen L, Qian LB, Ma LL,
Yu J, Zhu MH, Wen CY, Yu LN and Yan M: Both PI3K/Akt and ERK1/2
pathways participate in the protection by dexmedetomidine against
transient focal cerebral ischemia/reperfusion injury in rats. Brain
Res. 1494:1–8. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jin XF, Wang S, Shen M, Wen X, Han XR, Wu
JC, Tang GZ, Wu DM, Lu J and Zheng YL: Effects of rehabilitation
training on apoptosis of nerve cells and the recovery of neural and
motor functions in rats with ischemic stroke through the PI3K/Akt
and Nrf2/ARE signaling pathways. Brain Res Bull. 134:236–245. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kishikawa H, Kobayashi K, Takemori K,
Okabe T, Ito K and Sakamoto A: The effects of dexmedetomidine on
human neutrophil apoptosis. Biomed Res. 29:189–194. 2008.
View Article : Google Scholar : PubMed/NCBI
|
